FertiProt

Company Overview

Snapshot

Founded in October 2011 by Ronen Shemesh, PhD, FertiProt operated with 1–10 employees. The company developed an innovative gel formulation for fertility enhancement, focusing on non-invasive solutions.

Business overview

FertiProt developed an innovative technology centered on the evolutionary, chemical, and biological properties of the fertility process. The company's core product was a formulated protein, delivered as a gel or suppository, designed to enhance both male and female potency and increase the possibility of fertilization. This approach aimed to reduce the need for invasive hormonal treatments like IVF, serving couples with fertility impairment by improving the efficacy of artificial insemination or natural intercourse. FertiProt operated within the Health Tech & Life Sciences sector, specifically targeting the Pharmaceuticals and Medical Technologies industries globally.

Company Intelligence Q&A

What is FertiProt's primary focus?

FertiProt focuses on developing innovative technologies to enhance fertility, utilizing a gel formulation based on the evolutionary, chemical, and biological properties of the fertility process.

Who founded FertiProt?

FertiProt was founded by Ronen Shemesh, PhD.

What is the core product offered by FertiProt?

FertiProt's core product is a formulated protein, delivered as either a gel or a suppository, designed to increase the possibility of fertilization by enhancing male and female potency.

What problem does FertiProt's technology aim to solve?

FertiProt's technology aims to reduce the need for invasive hormonal-based treatments such as IVF by offering a non-invasive solution to increase the probability of conception for couples with fertility impairment.

When was FertiProt founded?

FertiProt was founded in October 2011.